Diffusion Pharmaceuticals Inc. 4
4 · Diffusion Pharmaceuticals Inc. · Filed May 12, 2017
Insider Transaction Report
Form 4
Kalergis David G
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2017-05-10+41,000→ 41,000 totalExercise: $2.95Exp: 2027-05-10→ Common Stock (41,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020.